Correlation Between Pardes Biosciences and Atea Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pardes Biosciences and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pardes Biosciences and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pardes Biosciences and Atea Pharmaceuticals, you can compare the effects of market volatilities on Pardes Biosciences and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pardes Biosciences with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pardes Biosciences and Atea Pharmaceuticals.

Diversification Opportunities for Pardes Biosciences and Atea Pharmaceuticals

-0.14

Correlation Coefficient

Pardes Biosciences  Atea Pharmaceuticals

Good diversification

The 3 months correlation between Pardes and Atea is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Pardes Biosciences and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Pardes Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pardes Biosciences are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Pardes Biosciences i.e., Pardes Biosciences and Atea Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pardes Biosciences and Atea Pharmaceuticals

If you would invest  357.00  in Atea Pharmaceuticals on July 19, 2024 and sell it today you would earn a total of  20.00  from holding Atea Pharmaceuticals or generate 5.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Pardes Biosciences  vs.  Atea Pharmaceuticals

Pardes Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Atea Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Atea Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak forward indicators, Atea Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Pair Trading with Pardes Biosciences and Atea Pharmaceuticals

The main advantage of trading using opposite Pardes Biosciences and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pardes Biosciences position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.

The idea behind Pardes Biosciences and Atea Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.